US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Microbot Medical Inc. - Common Stock
(NQ:
MBOT
)
1.160
-0.040 (-3.33%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Microbot Medical Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025
October 15, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up
September 30, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System
September 17, 2024
Completion of enrollment expected in Q4 with FDA submission for commercialization anticipated by the end of 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System
August 22, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
MBOT Stock Earnings: Microbot Medical Meets EPS for Q2 2024
↗
August 14, 2024
MBOT stock results show that Microbot Medical met analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization
August 13, 2024
The ISO 13485 certification is a validation of the Company’s robust quality system
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System
August 01, 2024
The evaluation phase will explore the potential of integrating robotics, procedure planning and navigation into a single autonomous system
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center
July 18, 2024
As the third and final clinical site, Memorial Sloan Kettering Cancer Center joins Brigham Women’s Hospital and Baptist Hospital of Miami as sites for the pivotal human clinical trial
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial
July 09, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial
July 08, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial
July 03, 2024
Following the Company’s recent FDA approval to commence its pivotal human clinical trial, Baptist Hospital of Miami is the second clinical site to enroll in the trial
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
June 20, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
June 17, 2024
The Site Initiation Visit for the BWH clinical staff is complete and a shipment of LIBERTY investigational units was delivered
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
June 04, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
June 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
June 04, 2024
Via
Benzinga
Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
↗
June 04, 2024
Via
Benzinga
Dow Dips Over 300 Points; GameStop Shares Spike Higher
↗
June 03, 2024
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Monday's Intraday Session
↗
June 03, 2024
Via
Benzinga
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
June 03, 2024
Via
Benzinga
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
June 03, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
Crude Oil Down Over 3%; US Construction Spending Falls In May
↗
June 03, 2024
Via
Benzinga
Why Microbot Medical Stock Is Up
↗
June 03, 2024
Microbot Medical shares are trading higher Monday after the company announced that it has received FDA approval to proceed with its human clinical trial as part of its Investigational Device Exemption...
Via
Benzinga
Nasdaq Surges 150 Points; US Manufacturing PMI Rises In May
↗
June 03, 2024
Via
Benzinga
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
June 03, 2024
The trial will be conducted in the U.S. and its results will complement the preclinical data on the LIBERTY® Endovascular Robotic Surgical System, which together are expected to support a future 510(k)...
From
Microbot Medical Inc.
Via
GlobeNewswire
MBOT Stock Earnings: Microbot Medical Meets EPS for Q1 2024
↗
May 15, 2024
MBOT stock results show that Microbot Medical met analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™
April 29, 2024
The next step of the collaboration will explore potential future applications of the LIBERTY system, including its potential capabilities for remote endovascular procedures
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Shares Status Following Recent Geopolitical Events
April 15, 2024
From
Microbot Medical Inc.
Via
GlobeNewswire
MBOT Stock Earnings: Microbot Medical Misses EPS for Q4 2023
↗
March 27, 2024
MBOT stock results show that Microbot Medical missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US
February 05, 2024
The Investigational Device Exemption (IDE) application follows the completion of multiple activities necessary to file this application
From
Microbot Medical Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
